HTFL · ISSUER CIK 1464521
Heartflow, Inc.
Between Jul 31, 2026 and Oct 28, 2026, 4 Heartflow, Inc. insiders reported $0.00 of open-market purchases and $15.5M of sales on SEC Form 4.
↗4 insiders filed
Original Form 4 filings from Jul 31, 2026 to Oct 28, 2026. 13 of 13 sales were reported under a 10b5-1 plan.
$0.00Insider buying
$15.5MInsider selling
−$15.5MNet open-market
Oct 26, 2026Latest filing
| Ticker | Insider | Type | Owned | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 26, 202618:00 | Oct 22, 2026 | HTFL | Chief Medical Officer | S · Sell10b5-1 | $55.01 | −23,933 | 73,453 | -25% | −$1.3M | ||
| Oct 26, 202618:00 | Oct 22, 2026 | HTFL | Chief Medical Officer | M · Exercise10b5-1 | $6.54 | +17,430 | 97,386 | +22% | $114K | ||
| Oct 14, 202618:05 | Oct 12, 2026 | HTFL | Chief Executive Officer, Director | S · Sell10b5-1 | $49.57 | −38,900 | 283,014 | -12% | −$1.9M | ||
| Sep 21, 202618:19 | Sep 18, 2026 | HTFL | Chief Medical Officer | S · Sell10b5-1 | $50.15 | −19,682 | 79,956 | -20% | −$987K | ||
| Sep 21, 202618:19 | Sep 18, 2026 | HTFL | Chief Medical Officer | M · Exercise10b5-1 | $7.94 | +13,179 | 99,638 | +15% | $105K | ||
| Sep 18, 202620:46 | Sep 18, 2026from Sep 17, 2026 | HTFL | Chief Financial Officer | S · Sell10b5-1 | $50.55 | −24,345 | 155,183 | -14% | −$1.2M | ||
| Sep 15, 202619:44 | Sep 15, 2026from Sep 11, 2026 | HTFL | Chief Financial Officer | S · Sell10b5-1 | $50.08 | −34,975 | 179,528 | -16% | −$1.8M | ||
| Sep 14, 202618:41 | Sep 11, 2026from Sep 10, 2026 | HTFL | Chief Executive Officer, Director | S · Sell10b5-1 | $46.78 | −38,900 | 321,914 | -11% | −$1.8M | ||
| Sep 10, 202617:24 | Sep 8, 2026 | HTFL | Chief Financial Officer | S · Sell10b5-1 | $50.03 | −6,640 | 214,503 | -3% | −$332K | ||
| Sep 4, 202617:29 | Sep 3, 2026from Sep 2, 2026 | HTFL | Chief Financial Officer | S · Sell10b5-1 | $49.85 | −33,416 | 221,143 | -13% | −$1.7M | ||
| Aug 25, 202617:32 | Aug 21, 2026 | HTFL | Chief Executive Officer, Director | S · Sell10b5-1 | $50.00 | −27,230 | 360,814 | -7% | −$1.4M | ||
| Aug 20, 202617:56 | Aug 18, 2026 | HTFL | Chief Executive Officer, Director | S · Sell10b5-1 | $45.00 | −32,676 | 388,044 | -8% | −$1.5M | ||
| Aug 19, 202621:04 | Aug 17, 2026 | HTFL | Chief Medical Officer | S · Sell10b5-1 | $41.23 | −9,219 | 86,459 | -10% | −$380K | ||
| Aug 19, 202621:04 | Aug 17, 2026 | HTFL | Chief Medical Officer | M · Exercise10b5-1 | $19.00 | +9,219 | 95,678 | +11% | $175K | ||
| Aug 18, 202618:38 | Aug 14, 2026 | HTFL | Chief Executive Officer, Director | S · Sell10b5-1 | $39.06 | −15,560 | 420,720 | -4% | −$608K | ||
| Aug 12, 202617:07 | Aug 10, 2026 | HTFL | Chief Executive Officer, Director | S · Sell10b5-1 | $28.31 | −22,562 | 436,280 | -5% | −$639K | ||
| Aug 10, 202617:21 | Aug 7, 2026from Aug 6, 2026 | HTFL | Chief Accounting Officer | F · Tax | $27.43 | −568 | 32,176 | -2% | $16K | ||
| Aug 10, 202617:21 | Mar 6, 2026 | HTFL | Chief Accounting Officer | A · GrantLate 157d | $16.15 | +1,661 | 33,311 | +5% | $27K | ||
| Aug 10, 202617:19 | Aug 7, 2026from Aug 6, 2026 | HTFL | Chief Financial Officer | F · Tax | $27.57 | −2,010 | 254,559 | -1% | $55K | ||
| Aug 10, 202617:19 | Mar 6, 2026 | HTFL | Chief Financial Officer | A · GrantLate 157d | $16.15 | +671 | 213,534 | +0% | $11K | ||
| Aug 10, 202617:17 | Aug 7, 2026from Aug 6, 2026 | HTFL | Chief Medical Officer | F · Tax | $27.65 | −2,272 | 86,459 | -3% | $63K | ||
| Aug 10, 202617:15 | Aug 7, 2026from Aug 6, 2026 | HTFL | Chief Executive Officer, Director | F · Tax | $27.59 | −7,751 | 458,842 | -2% | $214K | ||
| Jul 31, 202618:16 | Jul 30, 2026 | HTFL | Chief Executive Officer, Director | M · Exercise | $5.06 | +31,220 | 466,593 | +7% | $158K |